Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Walking Ability of Patients With Multiple Sclerosis Using the EXOPULSE Suit: Randomized Controlled Crossover Trial

NCT07252895 is registered in ClinicalTrials.gov with Otto Bock France SNC as lead sponsor.

NCT NCT07252895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07252895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Walking Ability of Patients With Multiple Sclerosis Using the EXOPULSE Suit: Randomized Controlled Crossover Trial
Lead sponsor
Otto Bock France SNC
Phase
Not applicable
Overall status
Recruiting
Start date
March 30, 2026
Completion date
March 31, 2027
Enrollment
77 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis